These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18506850)

  • 21. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain.
    Bergeron M; Gidday JM; Yu AY; Semenza GL; Ferriero DM; Sharp FR
    Ann Neurol; 2000 Sep; 48(3):285-96. PubMed ID: 10976634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes.
    Chu PW; Beart PM; Jones NM
    Eur J Pharmacol; 2010 May; 633(1-3):24-32. PubMed ID: 20153315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes.
    Germack R; Dickenson JM
    J Mol Cell Cardiol; 2005 Sep; 39(3):429-42. PubMed ID: 16005018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel.
    Zhao TC; Kukreja RC
    J Mol Cell Cardiol; 2002 Mar; 34(3):263-77. PubMed ID: 11945020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver.
    Ben-Ari Z; Pappo O; Sulkes J; Cheporko Y; Vidne BA; Hochhauser E
    Apoptosis; 2005 Oct; 10(5):955-62. PubMed ID: 16151631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ginkgolides mimic the effects of hypoxic preconditioning to protect C6 cells against ischemic injury by up-regulation of hypoxia-inducible factor-1 alpha and erythropoietin.
    He W; Qian Zhong M; Zhu L; Christopher Q; Du F; Yung WH; Ke Y
    Int J Biochem Cell Biol; 2008; 40(4):651-62. PubMed ID: 18054269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors.
    Guinzberg R; Cortés D; Díaz-Cruz A; Riveros-Rosas H; Villalobos-Molina R; Piña E
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E940-51. PubMed ID: 16352677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury.
    Dal Ponte C; Alchera E; Follenzi A; Imarisio C; Prat M; Albano E; Carini R
    Liver Transpl; 2011 Apr; 17(4):474-82. PubMed ID: 21445931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cellular resistance against Kupffer cell-derived oxidant stress: a novel concept of hepatoprotection by ischemic preconditioning.
    Schauer RJ; Gerbes AL; Vonier D; op den Winkel M; Fraunberger P; Bilzer M
    Hepatology; 2003 Feb; 37(2):286-95. PubMed ID: 12540778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ginkgolides induced ischemic tolerance and its possible molecular mechanism: experiment with rat pheochromocytoma cell line PC12].
    Chen J; Zhu L; Pan YJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2432-5. PubMed ID: 18036326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury.
    Lee HT; Emala CW
    J Am Soc Nephrol; 2002 Nov; 13(11):2753-61. PubMed ID: 12397046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors.
    Lee HT; Emala CW
    Am J Physiol Renal Physiol; 2000 Mar; 278(3):F380-7. PubMed ID: 10710542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia induces neurite outgrowth in PC12 cells that is mediated through adenosine A2A receptors.
    O'Driscoll CM; Gorman AM
    Neuroscience; 2005; 131(2):321-9. PubMed ID: 15708476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic preconditioning in liver pathophysiology.
    Arai M; Tejima K; Ikeda H; Tomiya T; Yanase M; Inoue Y; Nagashima K; Nishikawa T; Watanabe N; Omata M; Fujiwara K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S65-7. PubMed ID: 17567470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1.
    Chaudary N; Naydenova Z; Shuralyova I; Coe IR
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1190-8. PubMed ID: 15131243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine.
    Peralta C; Closa D; Xaus C; Gelpí E; Roselló-Catafau J; Hotter G
    Hepatology; 1998 Sep; 28(3):768-73. PubMed ID: 9731571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of adenosine A2a receptor accelerates and A2a receptor antagonist reduces intermittent hypoxia induced PC12 cell injury via PKC-KATP pathway.
    Singh BL; Chen L; Cai H; Shi H; Wang Y; Yu C; Chen X; Han X; Cai X
    Brain Res Bull; 2019 Aug; 150():118-126. PubMed ID: 31129168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry.
    Teoh N; Dela Pena A; Farrell G
    Hepatology; 2002 Jul; 36(1):94-102. PubMed ID: 12085353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
    Rogachev B; Ziv NY; Mazar J; Nakav S; Chaimovitz C; Zlotnik M; Douvdevani A
    Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of ischemic preconditioning on leukocyte participation in retinal ischemia-reperfusion injury.
    Nonaka A; Kiryu J; Tsujikawa A; Yamashiro K; Nishijima K; Miyamoto K; Nishiwaki H; Honda Y; Ogura Y
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2380-5. PubMed ID: 11527953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.